Tredje AP-fonden
Institutional investor · Portfolio as of Q1 2019
Top Holdings434 positions
ISHARES U.S. HEALTHCARE ETF | 416,000 | $80.6M | 4.2% | $35.71 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp | 602,840 | $71.1M | 3.7% | $110.12 | 0.00% | 1 qtr | First report 0 |
Apple Inc | 321,960 | $61.2M | 3.2% | $45.22 | 0.00% | 1 qtr | First report 0 |
Amazon.com Inc | 25,171 | $44.8M | 2.3% | $89.04 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 252,892 | $35.4M | 1.8% | $113.77 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc | 27,374 | $32.2M | 1.7% | $58.29 | 0.00% | 1 qtr | First report 0 |
Verizon Communications Inc | 504,415 | $29.8M | 1.5% | $38.16 | 0.00% | 1 qtr | First report 0 |
Facebook Inc | 172,239 | $28.7M | 1.5% | $165.11 | 0.00% | 1 qtr | First report 0 |
Pfizer Inc | 653,032 | $27.7M | 1.4% | $28.06 | 0.00% | 1 qtr | First report 0 |
Merck & Co Inc | 325,583 | $27.3M | 1.4% | $63.02 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc | 22,480 | $26.4M | 1.4% | $58.12 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co | 249,442 | $25.3M | 1.3% | $82.70 | 0.00% | 1 qtr | First report 0 |
Exxon Mobil Corp | 310,181 | $25.1M | 1.3% | $58.62 | 0.00% | 1 qtr | First report 0 |
Visa Inc | 151,363 | $23.6M | 1.2% | $148.12 | 0.00% | 1 qtr | First report 0 |
Procter & Gamble Co/The | 203,250 | $21.1M | 1.1% | $85.93 | 0.00% | 1 qtr | First report 0 |
Intel Corp | 388,307 | $20.9M | 1.1% | $46.51 | 0.00% | 1 qtr | First report 0 |
Abbott Laboratories | 255,207 | $20.4M | 1.1% | $69.76 | 0.00% | 1 qtr | First report 0 |
Berkshire Hathaway Inc | 99,131 | $19.9M | 1.0% | $200.89 | 0.00% | 1 qtr | First report 0 |
Bank of America Corp | 683,568 | $18.9M | 1.0% | $23.03 | 0.00% | 1 qtr | First report 0 |
UnitedHealth Group Inc | 74,309 | $18.4M | 1.0% | $217.04 | 0.00% | 1 qtr | First report 0 |
Tredje AP-fonden manages $1.9B across 434 positions as of Q1 2019. Top holdings: IYH (4.2%), MSFT (3.7%), AAPL (3.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
First quarter we have for this fund: 434 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $1.9B across 434 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR